Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal Ring
"Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Intrastromal Corneal Ring for Treatment of Keratoconus and Others Irregulars Astigmatisms."
1 other identifier
interventional
31
1 country
1
Brief Summary
The purpose of this study is to postpone the corneal transplantation in keratoconus and promote the stiffness of the cornea across the riboflavin-UVA corneal collagen crosslinking , and after, corneal ring surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 29, 2009
CompletedFirst Posted
Study publicly available on registry
January 30, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedJanuary 7, 2011
January 1, 2011
8 months
January 29, 2009
January 6, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Refractive data, visual acuity, topography patterns, pachymetry measurements.
Two years
Secondary Outcomes (1)
Anterior segment tomography data, corneal biomechanics, impression cytology.
Two years
Study Arms (2)
Eyedrop
SHAM COMPARATORCrosslinking
ACTIVE COMPARATORThe patients will be submitted to corneal collagen crosslinking, by use riboflavin eyedrop with UVA light.
Interventions
The patients will be submitted to corneal collagen crosslinking, that consists: Instillation of riboflavin eyedrop in the cornea for thirty minutes, and after, the patient will stay under the Crosslinking equipment, for more thirty minutes, also receiving riboflavin eyedrop.
Eligibility Criteria
You may qualify if:
- Patients with keratoconus
- Patients that aren't using contact lenses
- Pachymetry more than 400Um
- Best visual acuity less or equal 20/30
You may not qualify if:
- Ocular surgeries before
- Other eye diseases
- Corneal curvature more than 65 dioptres
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of São Paulo
São Paulo, São Paulo, 04038-000, Brazil
Related Publications (4)
Mencucci R, Mazzotta C, Rossi F, Ponchietti C, Pini R, Baiocchi S, Caporossi A, Menchini U. Riboflavin and ultraviolet A collagen crosslinking: in vivo thermographic analysis of the corneal surface. J Cataract Refract Surg. 2007 Jun;33(6):1005-8. doi: 10.1016/j.jcrs.2007.03.021.
PMID: 17531694BACKGROUNDCoskunseven E, Kymionis GD, Tsiklis NS, Atun S, Arslan E, Jankov MR, Pallikaris IG. One-year results of intrastromal corneal ring segment implantation (KeraRing) using femtosecond laser in patients with keratoconus. Am J Ophthalmol. 2008 May;145(5):775-9. doi: 10.1016/j.ajo.2007.12.022. Epub 2008 Mar 4.
PMID: 18291344BACKGROUNDWollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg. 2004 Mar;30(3):689-95. doi: 10.1016/j.jcrs.2003.11.032.
PMID: 15050269RESULTRenesto Ada C, Melo LA Jr, Sartori Mde F, Campos M. Sequential topical riboflavin with or without ultraviolet a radiation with delayed intracorneal ring segment insertion for keratoconus. Am J Ophthalmol. 2012 May;153(5):982-993.e3. doi: 10.1016/j.ajo.2011.10.014. Epub 2012 Jan 20.
PMID: 22265143DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adimara C Renesto, MD
Federal University of São Paulo
- STUDY CHAIR
Mauro S Campos, MD
Federal University of São Paulo
- STUDY CHAIR
Marta F Sartori, MD
Federal University of São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 29, 2009
First Posted
January 30, 2009
Study Start
March 1, 2008
Primary Completion
November 1, 2008
Study Completion
October 1, 2010
Last Updated
January 7, 2011
Record last verified: 2011-01